These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 6197100)

  • 41. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report.
    Shaywitz BA; Cohen DJ; Bowers MB
    J Pediatr; 1977 Jan; 90(1):67-71. PubMed ID: 830896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats.
    Becker JB; Adams F; Robinson TE
    J Neurosci Methods; 1988 Jul; 24(3):259-69. PubMed ID: 2458511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
    Extein I; Van Woert M; Roth RH; Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of intraventricular methotrexate on cerebrospinal fluid monoamine metabolites in rhesus monkeys.
    Johnston MV; Silverstein FS; Greenberg H; Knutsen CA; Chandler W; Phillips T; Ensminger WD
    Cancer Treat Rep; 1986 Oct; 70(10):1205-9. PubMed ID: 2428491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biogenic amines in 47, XYY syndrome.
    Bioulac B; Benezech M; Renaud B; Roche D; Noël B
    Neuropsychobiology; 1978; 4(6):366-70. PubMed ID: 692839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.
    Bowers MB; Study RE
    Psychopharmacology (Berl); 1979 Mar; 62(1):17-22. PubMed ID: 220657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK; Post RM
    Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
    [No Abstract]   [Full Text] [Related]  

  • 49. 3,4-Dihydroxyphenylethylamine and 5-hydroxytryptamine metabolism in the rat: acidic metabolites in cisternal cerebrospinal fluid before and after giving probenecid.
    Curzon G; Hutson PH; Kantamaneni BD; Sahakian BJ; Sarna GS
    J Neurochem; 1985 Aug; 45(2):508-13. PubMed ID: 2409231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 52. REM sleep eye movement activity and CSF concentrations of 5-hydroxyindoleacetic acid in psychiatric patients.
    Benson KL; Zarcone VP; Faull KF; Barchas JD; Berger PA
    Psychiatry Res; 1983 Jan; 8(1):73-8. PubMed ID: 6188182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cerebrospinal fluid biochemistry and diagnosis. Part II. Clinical biochemistry of monoamines and amino acids. Summary].
    Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):624-7. PubMed ID: 1015385
    [No Abstract]   [Full Text] [Related]  

  • 54. Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children.
    Winsberg BG; Sverd J; Castells S; Hurwic M; Perel JM
    Neuropediatrics; 1980 Aug; 11(3):250-5. PubMed ID: 6158716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid, lactic acid, and pH before and after probenecid in hepatic coma.
    Lal S; Aronoff A; Garelis E; Sourkes TL; Young SN; de la Vega CE
    Clin Neurol Neurosurg; 1975 Dec; 77(2):142-52. PubMed ID: 236851
    [No Abstract]   [Full Text] [Related]  

  • 56. CSF homovanillic acid: an index of dopaminergic activity.
    Curzon G
    Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CSF monoamine metabolites of depressed patients during illness and after recovery.
    Träskman-Bendz L; Asberg M; Bertilsson L; Thorén P
    Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of ECT and imipramine treatment on the concentration of 5-hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) in the cerebrospinal fluid of depressed patients.
    Jori A; Dolfini E; Casati C; Argenta G
    Psychopharmacologia; 1975 Oct; 44(1):87-90. PubMed ID: 1105628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [5-HIAA and HVA levels in the cerebrospinal fluid of hydrocephalic patients].
    Massarotti M; Migliore A; Roccella P; Toffano G
    Acta Neurol (Napoli); 1976; 31(5):601-13. PubMed ID: 1015383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.